Public Awareness of HPV and HPV Vaccine Remains Low, Especially in Midwest and South, Study Finds
New data show more than one-third of US adults are unaware of HPV or the HPV vaccine, with gaps greatest in the Midwest and South, where HPV-related cancers are most common.
Viking's Oral Dual Incretin Agonist VK2735 Produces Up to 12% Weight Loss at 13 Weeks in Midstage Trial
The GLP-1/GIP receptor agonist also showed promise in an exploratory maintenance arm, producing rapid weight loss at an induction dose that was sustained after down-titration.
GLP-1 Eligibility High Among US Youth, but Insurance Gaps Limit Access: Daily Dose
Your daily dose of the clinical news you may have missed.
Vaccine Policy Shifts, Public Trust, and Countering Misinformation
Infectious disease expert Amesh Adalja, MD, discusses new vaccine policies, misinformation, and how PCPs can build confidence during National Immunization Awareness Month.
The ACIP's Rich History of Debate is in Jeopardy, Not A Good Sign for Science, ID Expert Says
"The foundation of science in the new iteration of the ACIP is uncertain at best," William Schaffner, MD, observed. He is concerned about where that might lead.
Preparing for the 2025-26 Respiratory Virus Season: A Q&A With Sarah Sams, MD
Family physician Sarah Sams, MD, shares practical strategies on vaccine updates, coadministration, and addressing hesitancy this respiratory season.
Investigational Psychedelic RE104 for Postpartum Depression Delivers Positive Phase 2 Results: Reunion Neuroscience Update
In the RE104 group receiving the 30-mg dose, clinically meaningful reductions in the primary endpoint were seen on day 1 posttreatment and sustained through day 28 follow-up.
FluMist Intranasal Flu Vaccine Now Available for At-Home Delivery and Self-Administration
AstraZeneca launches FluMist Home, the first FDA-approved at-home flu vaccine service, allowing self- or caregiver administration of the intranasal influenza vaccine for the 2025–26 season.
Pharmacy-Based FIT Distribution Could Broaden CRC Screening, But Results Must be Delivered with Care, New Survey Reveals
If FIT results indicated colonoscopy, respondents preferred personal follow-up vs digital; significant barriers to undergoing fear of the test and positive cancer finding were the most significant barriers to follow-up.
More US Adults in Their 40s Undergoing CRC Screening After Age Threshold Lowered: Daily Dose
FDA Approves Semaglutide 2.4 mg for Treatment of MASH Without Cirrhosis
The accelerated approval for semaglutide 2.4 mg for the treatment of noncirrhotic MASH was based on part 1 of the phase 3 ESSENCE trial, which met its primary endpoints.
New Fibromyalgia Treatment: FDA Approves Once-Daily Nonopioid Analgesic TNX-102 SL
The US FDA approved Tonmya, a groundbreaking treatment for fibromyalgia, offering hope to millions experiencing chronic pain and sleep issues.
AHA/ACC Release Revised Hypertension Clinical Practice Guideline to Reduce CVD Risk
Updates to the 2017 guideline focus on new monitoring strategies, earlier intervention to reduce cognitive decline, improved perinatal care, and refined risk assessment.
The Weekly Dose: New Endocrine Guidelines, Digital Asthma Gains, AI Trust Gap, GLP-1 & Dementia Risk, First CHE Treatment
Explore the latest insights on diabetes in pregnancy, asthma management disparities, AI in health care, dementia risk reduction, and new eczema treatments.
The 5 Essential Adult Vaccines: What Your Patients Need to Know
Please remind your adult patients that these recommended vaccines (eg, pneumococcal, flu, HPV) are essential to protect them, and their communities, from serious outcomes.
GLP-1 RAs Prescribed for More Than One-Third of US Adults With Diabetes in Middle Age: NCHS Data Brief
GLP-1 use among adults with diabetes peaked among those aged 50 to 64 years, was highest among Hispanic adults, and was more likely among those taking other antihyperglycemic agents.
Lecanemab Shows Sustained Benefit at 4 Years in Early Alzheimer Disease: Daily Dose
Combating Vaccine Misinformation: Q&A With Amesh Adalja, MD
Infectious disease expert Amesh Adalja, MD, discusses key vaccine policy changes, strategies to combat misinformation, and ways PCPs can boost vaccine confidence.
KFF COVID-19 Vaccine Survey: Policy Shifts, Trust Gaps, and Vaccine Intentions
A recent poll reveals most US adults are hesitant about fall COVID-19 vaccinations, highlighting confusion over federal policies and declining trust in health agencies.
How Would You Advise An Infectious Disease Resident About a Career Path Today? This Expert Isn't Sure
William Schaffner, MD, a veteran infectious disease expert and public health thought leader is concerned that rapidly shifting federal policy could impact future options.
.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "Vaccine Policy Shifts, Public Trust, and Countering Misinformation")
.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "Preparing for the 2025-26 Respiratory Virus Season: A Q&A With Sarah Sams, MD")
